Actinium Pharmaceuticals
ATNM
#10403
Rank
NZ$79.88 M
Marketcap
NZ$2.54
Share price
-3.38%
Change (1 day)
5.36%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): NZ$17.41 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$35.09 Million. In 2025 the company made an earning of -NZ$64.41 Million, an increase over its 2024 earnings that were of -NZ$74.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$17.41 M-127.05%
2025 -NZ$64.41 Million-13.95%
2024 -NZ$74.84 Million-18.87%
2023 -NZ$92.25 Million52.24%
2022 -NZ$60.6 Million36.61%
2021 -NZ$44.36 Million11.48%
2020 -NZ$39.79 Million1.46%
2019 -NZ$39.22 Million-7.37%
2018 -NZ$42.34 Million-11.46%
2017 -NZ$47.82 Million10.67%
2016 -NZ$43.21 Million15.7%
2015 -NZ$37.35 Million-14.86%
2014 -NZ$43.87 Million129.19%
2013 -NZ$19.14 Million-8.55%
2012 -NZ$20.93 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$66.08 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA